Identification Biomarkers and Molecular Mechanisms Involved in Lung Transplant Rejection, and Drug Repurposing: A Systems Biology Study

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 28

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ZUMS-31-149_002

تاریخ نمایه سازی: 20 فروردین 1403

چکیده مقاله:

Background and Objective: Lung transplantation is a promising  therapy for patients with end-stage lung disease. Pulmonary surfactant is a lipid and protein complex which has  a key role in lung function. Molecular mechanisms mediating in rejection of lung transplantation related to surfactants are not still comprehensively understood. In this study, we applied bioinformatics approaches to identify genes and molecular mechanisms involved in surfactant function in rejection of lung transplantation. Materials and Methods: At first, transcriptomics data was extracted and analyzed to construct the protein-protein interaction network and gene regulatory network using Cytoscape. Then, networks analysis were performed to determine hubs, bottlenecks, clusters, and regulatory motifs to identify critical genes and molecular mechanisms involve in surfactant function in rejection of lung transplantation. Finally, critical genes selected for repuposing drugs. Results: Analyzing the constructed PPIN and GRN identified SCD, FN۱, ICAM۱, ITGB۸, FOXC۱, SIX۱, FHL۲, KRT۵, TFAP۲A, GAS۵, MALAT۱, and lnrCXCR۴ as critical genes. Enrichment analysis showed the genes are enriched for pulmonary surfactant metabolism dysfunction, defective CSF۲RB causes pulmonary surfactant metabolism dysfunction ۴ and ۵, Interleukin-۴ and Interleukin-۱۳ signaling  may be the mechanisms for surfactant function in rejection of lung transplantation. We predicted some candidate drugs for preventing of lung transplantation rejection such as Sunitinib, Gemcitabine, Oxaliplatin, Hyaluronic acid, … . Conclusion: Following our model validation using the existing experimental data, our model suggested critical molecules and candidate medicines involve in  surfactant function in rejection of lung transplantation for furtur investigations.

نویسندگان

Seyed Amir Mirmotalebisohi

Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Zeinab Dehghan

Dept. of Comparative Biomedical Sciences, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran

Abbas Alibakhshi

Molecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran

Fatemeh Yarian

Dept. of Medical Biotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran

Hakimeh Zali

Dept. of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • References۱. Singer JP, Katz PP, Soong A, Shrestha P, Huang ...
  • Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, ...
  • de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia–reperfusion–induced ...
  • Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant ...
  • Griese M. Pulmonary surfactant in health and human lung diseases: ...
  • Halloran K, Parkes MD, Timofte I, Snell G, Westall G, ...
  • Halloran PF, Potena L, Van Huyen J-PD, Bruneval P, Leone ...
  • Bontha S, Maluf D, Mueller T, Mas V. Systems Biology ...
  • Halloran KM, Parkes MD, Chang J, Timofte IL, Snell GI, ...
  • Trulock E. Management of lung transplant rejection. Chest. ۱۹۹۳;۱۰۳(۵):۱۵۶۶-۷۶ ...
  • Okuda R, Matsushima H, Aoshiba K, Oba T, Kawabe R, ...
  • Zhang F, Pan T, Nielsen LD, Mason RJ. Lipogenesis in ...
  • Fjellbirkeland L, Cambier S, Broaddus VC, Hill A, Brunetta P, ...
  • DerHovanessian A, Weigt SS, Palchevskiy V, Shino MY, Sayah DM, ...
  • Ou‑Yang L, Xiao SJ, Liu P, Yi SJ, Zhang XL, ...
  • Wilson C, Collum S, Hernandez A, Mertens T, Headley L, ...
  • Dierck F, Kuhn C, Rohr C, Hille S, Braune J, ...
  • Uchida S, Dimmeler S. Long noncoding RNAs in cardiovascular diseases. ...
  • Vaughan AE, Brumwell AN, Xi Y, Gotts JE, Brownfield DG, ...
  • Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. New England Journal ...
  • Needleman D, Dogic Z. Active matter at the interface between ...
  • Brown L, Pasquale SM, Longmore WJ. Role of microtubules in ...
  • Satir P, Christensen ST. Overview of structure and function of ...
  • Suryadinata R, Levin K, Holsworth L, Paraskeva M, Robinson P. ...
  • Brokaw C, Kamiya R. Bending patterns of Chlamydomonas flagella: IV. ...
  • Pastva AM, Wright JR, Williams KL. Immunomodulatory roles of surfactant ...
  • Tanaka T, Motoi N, Tsuchihashi Y, Tazawa R, Kaneko C, ...
  • Amital A, Shitrit D, Raviv Y, Saute M, Medalion B, ...
  • Paul WE. History of interleukin-۴. Cytokine. ۲۰۱۵;۷۵(۱):۳-۷ ...
  • Jain-Vora S, Wert SE, Temann U-A, Rankin JA, Whitsett JA. ...
  • Hedges JC, Singer CA, Gerthoffer WT. Mitogen-activated protein kinases regulate ...
  • Zhou Y, Xu W, Zhu H. CXCL۸ (۳-۷۲) K۱۱R/G۳۱P protects ...
  • ISHIHARA A, YAMASHITA Y, TAKAMORI H, KURODA N. FDA approves ...
  • Courtwright AM, Lamattina AM, Louis PH, Trindade AJ, Burkett P, ...
  • Gundrum D, Brown K, Collingridge DS. Chemotherapy order second check ...
  • نمایش کامل مراجع